Finance And Related Services Tenders

Open House Drug Discount Contracts Lanthanum(Iii) Carbonate, Atc Code V03ae03

Open House Drug Discount Contracts Fondaparinux, Atc Code B01ax05

Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Drug Name Dysport(R)/Dysline(R), Atc Code M03ax21

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Buserelin (Atc Code: L02ae01).

Medicine Discount Contracts in Accordance with Section 130A Paragraph 8 Sgb V as Part of Open House Procedures

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Etravirine, Atc J05ag04 (Obo) for the Period July 1St, 2024 - June 30Th, 2026

Medicine Discount Contracts in Accordance with Section 130A Paragraph 8 Sgb V as Part of Open House Procedures

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Ixekizumab, Atc L04ac13 (Obo) for the Period July 1St, 2024 - June 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Dornase Alfa, Atc R05cb13 (Obo) for the Period July 1St, 2024 - June 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Piribedil, Atc N04bc08 (Obo) for the Period July 1, 2024 - June 30, 2025 (One-Year Extension Option)